Skip to contentC
Catheter Precision, Inc.
C
VJETCatheter Precision, Inc. Q3 2025 · 10-Q
Revenue$226.00K$226.00K+135.4% vs Q3 2024 Net Income-$2.25M-$2.25MN/M vs Q3 2024 EPS, diluted—
Gross Profit$208,000+141.9% Operating Income-$3,021,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Catheter Precision, Inc. · CIK 1716621 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,183,000N/M Free Cash Flowderived-$2,183,000N/M Margins · derivedGross margin92.0%+2.5 pt vs Q3 2024
Operating margin-1336.7%+1641.4 pt vs Q3 2024
Net margin-996.0%+3295.6 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 13, 2025 · 44 d after period end